DH-XP-0090

N/A

Report date: 2025/06/11 10:19:49

NME

Base Information

Drug NameDH-XP-0090

Drug Alias NameXIAP inhibitors (University at Buffalo/Roswell Park Cancer Institute)D-12 (University of Buffalo/Roswell Park Cancer Institute)XIAP inhibitors (University at Buffalo/Roswell Park Comprehensive Cancer Center)DP-12DH-XP-0090

ClassificationSmall molecules

Mechanisms of ActionInhibitor of apoptosis protein 3 inhibitorsApoptosis stimulants

TargetsInhibitor of apoptosis protein 3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity At Buffalo

China Registration ClassN/A

Develop Information

Active CompaniesRoswell Park Comprehensive Cancer Center University At Buffalo

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A